Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year

APTA Results (5,268 Results)

Includes articles, courses, and CPGs. Unlimited access for APTA members.

Study: Knee, Hip OA May Increase Risk of CVD-Related Death, Underscoring Need for Emphasis on Physical Activity in OA Treatment

Aug 16, 2019/Review

Those with hip or knee OA died from chronic ischemic heart diseases and heart failure at a greater rate.

Coronavirus Reports: What We Know, and What We Don't

Mar 3, 2020/Roundup

A roundup of what was being reported by public health and infectious disease experts at the time.

Defining Moment | What Is Physical Therapy, Really?

Dec 1, 2025/Column

A chance conversation with an old friend opened one PT's eyes to how easily patient trust can be lost.

The Good Stuff: Members and the Profession in the Media, May 2020

May 13, 2020/News

Highlighting recent, mostly local media coverage of physical therapy and APTA members.

The Good Stuff: Members and the Profession in the Media, February 2022

Feb 16, 2022/Roundup

Members are being sought out for their expertise and insight. Check out this month's collection.

The PT/PTA Billing Dynamics

Jul 26, 2018/Perspective

The provision and billing of services when provided by a PT-PTA team is complex.

APTA Report: Pandemic Continues to Disrupt Physical Therapy Profession

Aug 17, 2020/News

Responses to July survey show a profession that is challenged, adapting, and steadfast.

Telehealth Ethics, Best Practice, and the Law: What You Need to Know

Aug 27, 2019/Article

As practice expands to telehealth, securing patients' protected health information is more critical than ever before.

An Ethical Exploration of Microaggressions in Physical Therapy: Insight From APTA's Ethics & Judicial Committee

May 21, 2024/Podcast

Intentional or not, small slights have a large impact.

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022/CPG

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]